Sourced from:Manufacturer Authorized Distributor
Quick Summary
Trustiva Tablet
Last updated on 31 Mar 2026 | 09:31 AM (IST)
₹1326
MRP: ₹3562.5
(You Save ₹2236.5)
30 TABLET(s) IN A BOTTLE
Trustiva Tablet is a prescription antiretroviral medicine used in the treatment of HIV-1 infection in adults. It is a fixed-dose combination of efavirenz, emtricitabine, and tenofovir disoproxil fumarate, which work together to inhibit viral replication and reduce viral load. Trustiva is taken under medical supervision as part of a long-term HIV treatment regimen.
Sourced from:Manufacturer Authorized Distributor
Trustiva Tablet
Salt Composition
EFAVIRENZ,EMTRICITABINE,TENOFOVIR DISOPROXIL FUMARATEMarketer
HETERO HEALTHCARE LTD
63% OFF
₹1326
MRP: ₹3,562.50
Inclusive of all taxes
63% Off
Salt Composition
EFAVIRENZ,EMTRICITABINE,TENOFOVIR DISOPROXIL FUMARATEMarketer
HETERO HEALTHCARE LTD
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Teevir Tablet
MYLAN PHARMACEU...
₹ 36.67/tablet
17% cheaper
Virashiv Tablet
SHIVNAAM TRADEL...
₹ 39.07/tablet
11% cheaper
Virarazer Tablet
APRAZER HEALTHC...
₹ 39.70/tablet
10% cheaper
Vonavir Tablet
EMCURE PHARMACE...
₹ 54.87/tablet
25% costlier


Introduction
Trustiva Tablets contain two active substances, Emtricitabine and Tenofovir disoproxil fumarate. These medications are a part of the standard combination therapy for HIV, known as antiretroviral therapy (ART). It is a combination drug regimen that is commonly used for the effective treatment of HIV-1 infection. When used correctly and consistently, Trustiva tablets have demonstrated high efficacy in HIV treatment and prevention.
Antiviral medications help postpone the effects of AIDS and enhance the overall quality of life. For individuals with high viral loads, this combo therapy is ideal. Although this medication greatly lowers the risk of viral infection, it does not treat HIV, and there are still chances that HIV will spread to other individuals. It is given to adults and kids over the age of 12 with a body weight of more than 35 kg.
These should not be used in individuals with known hypersensitivity or severe allergic reactions to Emtricitabine, Tenofovir disoproxil fumarate, or any medication components. This medication is not recommended in individuals with severe renal impairment or end-stage renal disease who are not receiving hemodialysis.
Uses
Trustiva Tablet is used to treat HIV-1 infection.
How Trustiva Tablet Works
Trustiva Tablet has therapeutic effects in treating HIV infection and pre-exposure prophylaxis (PrEP). They work by inhibiting HIV replication, reducing viral load, improving immune function, and slowing the progression of HIV disease. In individuals with HIV, these medications help control the virus, maintain a low viral load, and improve overall health outcomes.
Interaction of Trustiva Tablet with other drugs
Taking Trustiva Tablet (efavirenz + emtricitabine + tenofovir disoproxil fumarate) with any of the following medicines can change the effect of either of them and may increase the risk of serious side effects.
Rifampicin (Oral Route) Life-threatening
Use only under strict medical supervision.
Rifampicin may reduce efavirenz levels and decrease the effectiveness of HIV treatment.Carbamazepine, Phenytoin, or Phenobarbital (Oral Route) Life-threatening
Avoid using together.
These medicines may lower efavirenz levels and increase the risk of treatment failure.St John’s Wort (Herbal Route) Life-threatening
Do not take them together.
This herbal product may significantly reduce the effect of the medicine and lead to viral resistance.Voriconazole (Oral/Injection Route) Life-threatening
Avoid concomitant use.
Efavirenz may reduce voriconazole levels, while voriconazole may increase efavirenz levels, leading to reduced effectiveness or increased side effects.Atazanavir or other protease inhibitors (Oral Route) Moderate
Use with caution.
Dose adjustment may be required as efavirenz can alter blood levels of these medicines.
Storage Conditions
Store at a temperature between 20°C to 25°C (68°F to 77°F).
Keep away from moisture, heat, and light.
It should not be frozen.
Keep it in its original packaging.
Keep away from children and pets.
How to consume Trustiva Tablet
To properly consume Trustiva Tablet, follow your healthcare provider's instructions regarding dosage, frequency, and duration. Take it with or without food, swallowing the tablets or capsules with water. Adhere to the prescribed dosing schedule; do not alter the dosage without consulting your healthcare provider.
Safety Advice for Trustiva Tablet
Breast Feeding
Trustiva Tablet is excreted into human breast milk, but the potential risks to the infant are not well established. So patients should consult a doctor before taking it.
Alcohol
It is generally recommended to avoid excessive alcohol consumption while taking Trustiva Tablet or any medication. Alcohol can interact with this medication and affect liver function.
Liver
The safety of Trustiva Tablet in individuals with liver disease may depend on the specific type and severity of liver disease and other factors. It is important to consult with a healthcare provider.
Lungs
Suppose you have a history of lung disease or are experiencing respiratory symptoms while taking it. Then it is important to consult the healthcare provider for a thorough evaluation before taking Trustiva Tablet.
Driving
Some people experience side effects, including dizziness, drowsiness, or fatigue, while taking Trustiva Tablet. Suppose anyone experiences any of these side effects or any other symptoms that may interfere with your ability to drive safely. In that case, avoid driving or operating heavy machinery.
Pregnancy
If you are pregnant or plan to become pregnant, it is crucial to consult with your healthcare provider before taking Trustiva Tablet.
Side Effects
Trustiva Tablets cause side effects like all medications, although not everyone will experience them.
Serious:
Kidney problems or renal toxicity
Decreased bone mineral density or bone loss
Lactic acidosis (a huge accumulation of lactic acid in the blood)
Hepatic steatosis (fat accumulation in the liver)
Immune reconstitution syndrome (a paradoxical worsening of pre-existing infections or inflammatory conditions when the immune system strengthens)
Common:
Nausea
Diarrhea
Headache
Fatigue
Dizziness
Insomnia
Rash
Expert Tips
Before starting Trustiva Tablet, understand the possible risks and discuss them with your doctor.
Pregnancy and breastfeeding require careful medical evaluation to balance benefits and potential risks.
Use this medicine cautiously if you have liver disease, kidney disease, or bone disorders, as it may worsen these conditions.
Regular monitoring and proper medical management are important during treatment.
Stay in regular contact with your healthcare provider to ensure safe and effective use.
FAQs about Trustiva Tablet
Q1.
Can Trustiva Tablet be taken with other antiretroviral medications?
Trustiva Tablet is often combined with other antiretroviral medications as part of a multidrug regimen for treating HIV infection. The specific combination of medications will depend on individual health status, treatment history, and potential drug interactions
Q2.
Can Trustiva Tablet be safely used by older adults?
Trustiva Tablet can be used in older adults. Still, dosage adjustments or additional monitoring may be necessary, as age-related changes in kidney and liver function can affect medication clearance. It is important to discuss individual health status and any concerns with a healthcare provider.
Q3.
Can Trustiva Tablet be used in individuals with pre-existing bone conditions?
Individuals with pre-existing bone conditions, such as osteoporosis or osteopenia, may require careful monitoring and management when using Trustiva Tablet. It is important to discuss any underlying bone conditions with your healthcare provider to ensure appropriate bone health monitoring and potential supplementation.
Q4.
Can Trustiva Tablet prevent all forms of HIV transmission?
Trustiva Tablet, when used as PrEP, significantly reduces the risk of HIV transmission through sexual activity or injection drug use. However, they do not provide 100% protection against HIV, and it is important to continue practicing safe sex and taking other preventive measures.
Q5.
Can Trustiva Tablet cause lactic acidosis?
Although rare, Trustiva Tablet has been associated with the risk of lactic acidosis. Lactic acidosis is a serious condition characterized by the accumulation of lactic acid in the blood. It is important to promptly report any symptoms such as unusual weakness, rapid breathing, nausea, vomiting, abdominal pain, or unexplained muscle pain to your healthcare provider while taking it.
Q6.
Can Trustiva Tablet prevent all forms of HIV transmission?
Trustiva Tablet, when used as PrEP, significantly reduces the risk of HIV transmission through sexual activity or injection drug use. However, they do not provide 100% protection against HIV, and it is important to continue practicing safe sex and taking other preventive measures.
Q7.
Can Trustiva Tablet cause lactic acidosis?
Although rare, Trustiva Tablet has been associated with the risk of lactic acidosis. Lactic acidosis is a serious condition characterized by the accumulation of lactic acid in the blood. It is important to promptly report any symptoms such as unusual weakness, rapid breathing, nausea, vomiting, abdominal pain, or unexplained muscle pain to your healthcare provider while taking it.
Q8.
Are any specific tests or monitoring required for bone health while taking Trustiva Tablet?
Monitoring of bone mineral density may be recommended for individuals on long-term treatment with Tenofovir disoproxil fumarate. Your healthcare provider may request bone density scans or blood tests to assess bone health and determine if any interventions or additional treatments are necessary.
Q9.
Can Trustiva Tablet be used in individuals with liver or kidney disease?
Trustiva Tablets should be used cautiously in individuals with liver or kidney impairment. Dose adjustments or alternative treatment options may be necessary.
Fact Box
Molecule name: Emtricitabine and Tenofovir disoproxil fumarate | Therapeutic class: Antiviral agents |
Pharmacological class: Nucleoside reverse transcriptase inhibitors (NRTIs) | Indications: HIV- 1 Infection |
References
- KD Tripathi, Antiviral Drugs (Anti-retrovirus), Essentials of Medical Pharmacology, 8th Edition, 2019, 860-872.
- Tillomed Laboratories Limited, Electronic Medicines Compendium (EMC), [Revised on Apr 2020] [Accessed on 19th May 2023], https://www.medicines.org.uk/emc/files/pil.11636.pdf
- Gilead Sciences, Inc, US Food and Drug Administration, [ Revised on March 2016] [ Accessed on 19th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021752s047lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Archana Gupta
BDS

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:31 AM (IST)

Want to know more?
Read Our Editorial Policy







